Skip to main content

Table 1 Demographics

From: The diagnostic accuracy of spirometry as screening tool for adult patients with a benign subglottic stenosis

 

SGS patients (n = 50)

Asthma patients (n = 32) p-values

Female (n, %)

39 (78.0%)

21 (65.6%) p = 0.349

Age at spirometry test date in years

(median, IQR)

48.0 (38.5–60.3)

51.0 (39.5–66.5) p = 0.655

BMI at spirometry test date

(median, IQR)

26.1 (23.9–28.8)

26.7 (22.7–30.9) p = 0.766

Stenosis etiology (n, %)

  

Idiopathic

27 (54.0%)

 

GPA

13 (26.0%)

 

Amyloidosis

1 (2.0%)

 

Sarcoidosis

1 (2.0%)

 

Post-intubation

3 (6.0%)

 

Post-tracheotomy

4 (8.0%)

 

Post traumatic

1 (2.0%)

 

Asthma etiology (n, %)

  

Allergic

 

11 (34.4%)

Non-allergic

 

17 (53.1%)

Allergic bronchopulmonary aspergillosis

 

4 (12.5%)

Spirometry variables

(median, IQR) - %pred. value (median %)

  

FEV1 in liters

2.57 (2.06–3.14) – 86.0%

2.22 (1.78–3.09) – 83.0% p = 0.61

PEFR in liters/second

3.81 (3.15–5.20) – 60.6%

6.04(4.43–8.22) – 91.5% p = 0.00*

FVC in liters

3.83 (3.23–4.37) – 101.5%

3.31 (2.61–4.09) – 95.5% p = 0.06

VC in liters

3.33 (2.83–3.96) – 102.0%

3.88 (3.31–4.37) – 97.0% p = 0.14

  1. Demographic data of the “benign subglottic stenosis”(SGS) patients and the ‘asthma’ patients. GPA = Granulomatosis with polyangiitis (Wegener’s granulomatosis); FEV1 = Functional expiratory volume after 1 second; PEFR = Peak expiratory flow rate; FVC = Forced Vital Capacity; VC = Vital capacity. % pred. value = % predicted value of spirometry variables. GLI-2012 was used to as reference value for the pred. values [11]. P-values correspond to the differences testing between groups